Quick Takeaways
- This page summarizes Brian C. Evanko's Form 4 filing for Cigna Group (CI).
- 5 reported transactions and 2 derivative rows are listed below.
- Filing timestamp: 07 Oct 2025, 17:22.
Brian C. Evanko - 03 Oct 2025 Form 4 Insider Report for Cigna Group (CI)
- Signature
- Tyler Gratton, attorney-in-fact
- Issuer symbol
- CI
- Transactions as of
- 03 Oct 2025
- Net transactions value
- -$737,630
- Form type
- 4
- Filing time
- 07 Oct 2025, 17:22:53 UTC
- Previous filing
- 28 May 2025
- Next filing
- 03 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Brian C. Evanko filed Form 4 for Cigna Group (CI) on 07 Oct 2025."
What Changed
- Previous filing in this sequence was filed on 28 May 2025.
- Current net transaction value: -$737,630.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Evanko Brian C | President and Chief Operating Officer | 900 COTTAGE GROVE ROAD, BLOOMFIELD | Tyler Gratton, attorney-in-fact | 07 Oct 2025 | 0001722909 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CI | Common Stock, $.01 Par Value | Options Exercise | $747,333 | +5,368 | +10% | $139.22 | 56,550 | 03 Oct 2025 | Direct | F1 |
| transaction | CI | Common Stock, $.01 Par Value | Sale | $1,610,400 | -5,368 | -9.5% | $300.00 | 51,182 | 03 Oct 2025 | Direct | F1 |
| transaction | CI | Common Stock, $.01 Par Value | Options Exercise | $125,437 | +901 | +1.8% | $139.22 | 52,083 | 06 Oct 2025 | Direct | F1 |
| holding | CI | Common Stock, $.01 Par Value | 904 | 03 Oct 2025 | By 401(k) | F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CI | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -5,368 | -86% | $0.000000 | 901 | 03 Oct 2025 | Common Stock, $0.01 Par Value | 5,368 | $139.22 | Direct | F1, F3 |
| transaction | CI | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -901 | -100% | $0.000000 | 0 | 06 Oct 2025 | Common Stock, $0.01 Par Value | 901 | $139.22 | Direct | F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2025. |
| F2 | Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan. |
| F3 | This option was granted on March 1, 2016. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. |
Remarks:
President and Chief Operating Officer